Filing Details
- Accession Number:
- 0001437749-17-005086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-22 16:59:44
- Reporting Period:
- 2017-03-20
- Filing Date:
- 2017-03-22
- Accepted Time:
- 2017-03-22 16:59:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1586049 | Oxford Immunotec Global Plc | OXFD | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1629085 | M Elizabeth Keiley | C/O Oxford Immunotec Global Plc 94C Innovation Drive Abingdon, Oxfordshire X0 OX14 4RZ | Senior Vp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2017-03-20 | 3,000 | $0.81 | 25,429 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2017-03-20 | 3,000 | $16.05 | 22,429 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2017-03-20 | 8,185 | $0.81 | 30,614 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Share Option (Right to Buy) | Disposition | 2017-03-20 | 3,000 | $0.00 | 3,000 | $0.81 |
| Ordinary Shares | Share Option (Right to Buy) | Disposition | 2017-03-20 | 8,185 | $0.00 | 8,185 | $0.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,185 | 2022-09-30 | No | 4 | M | Direct | |
| 0 | 2022-09-30 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8 2016.
- Exercise from an option granted October 29, 2012, which became fully vested on September 30, 2016.
Billionaire Hedge Funds
